Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications considerations characterizing real‐world data relevance quality regulatory purposes
… determine if it is feasible and effective to use existing data sources, and if so, which data source(s), to answer your regulatory real-world evidence, epidemiology, and/or drug safety questions. …
… insights that emerged from the event: Genomic/Biomarker Data: Revolutionizing Cancer Treatment There is a push to … such as understanding how their product performs in real-world settings, identifying gaps in care, conducting studies …
… treatment for advanced or metastatic breast cancer in a US real-world setting. While there was a broad body of evidence on … to manage, monitor, and analyze multiple longitudinal data streams coming from disparate sources and systems. …
… depends on the strength of the model structure and the quality of the data, but it must also be flexible, transparent, and … analysis Our Approach From design to deliverables, publications , and ongoing support, we develop and validate …
… October 21, 2023 Conference website 30 Years of ISOQOL: Quality of Life – making it relevant. Research and … at 1:20 pm Presenting author: Nicholas Rockwood Design considerations for successful in-trial interviews: the who, … novel approaches to capturing the patient experience in quality of life research. Section 4. Presentation date and …
… Outline Best Practices for Collecting Patient Experience Data During the COVID-19 Outbreak Share on: April 9, 2020 … Of COVID-19 Vaccine Effects Post-Approval Related Services Real-World Evidence Patient-Centered Outcomes Assessment Staff …
… on: July 29, 2024 Contributed by: Emma Hawe, MSc Head, Data Analytics and Design Strategy RTI Health Solutions From … pressure on pharma biostatisticians, epidemiologists, and real-world researchers. There appears to be a highly compressed …
… on: July 25, 2024 Contributed by: Emma Hawe, MSc Head, Data Analytics and Design Strategy RTI Health Solutions Joint … extra information including that not in the JCA dossier. Quality, Transparency, and Timeliness The aim of JCAs is to … of the manufacturer. The process is kicked off when the regulatory dossier is submitted to the EMA. HTA Firmly in …
… related to the development, evaluation, and regulatory review of clinical outcome assessments and states …
… Health Economics: Database Studies Real world data—from administrative claims data, electronic medical …